Clinical Trials Browser

Phase 1/2 × Uterine Neoplasms × Imatinib Mesylate × Clear all

NCT00506779 2020-11-18

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

Phase 1/2 Terminated

17 enrolled 7 charts

Uterine Neoplasms